Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and Adenocarcinoma

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anisimov, VN; Belitskiĭ, GA; Kalvinysh, IIa; Khovanova, EM; Tolcheev, IuD; Ugvinenko, EG1

Other Studies

1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Adenocarcinoma

ArticleYear
[Absence of mutagenic and carcinogenic properties in Mildronate].
    Voprosy onkologii, 1999, Volume: 45, Issue:3

    Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Carcinogens; Drosophila melanogaster; Female; Mammary Neoplasms, Experimental; Methylhydrazines; Mice; Mice, Inbred Strains; Mutagens

1999